Common (5-15% of users): Mild injection site reactions, minor digestive changes Uncommon (1-5%): Sleep changes, temporary fatigue, mild headache Rare (under 1%): Dizziness, flushing, mood changes Very Rare: Serious adverse effects rarely reported in community use Theoretical Concerns BPC-157s ability to stimulate angiogenesis (blood vessel formation) raises theoretical questions about its use in individuals with active cancer or high cancer risk
This may happen because of certain stomach or bowel conditions, previous surgery, pernicious anaemia or other medical reasons
Calms irritation, reduces redness, and accelerates healing after procedures
Symptoms of intoxication may appear several hours after administration of the substance
doi:10.1016/j.gene.2022.146663 Langan RC, Goodbred AJ